3D Systems, Inc. (US), Evonik Industries AG (Germany), Stratasys Ltd. (US), Concept Laser, GmBH (Germany), EOS GmBH Electro Optical Systems (Germany) are the Renowned Players in Biocompatible 3D Printing Materials Market - Report by MarketsandMarkets™

According to recent research "Biocompatible 3D Printing Materials Market by Type (Polymer, Metal), Application (Implants & Prosthesis, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aid), Form (Powder, Liquid), and Region - Global Forecast to 2023", published by MarketsandMarkets™, The biocompatible 3D printing materials market is projected to grow from the estimated USD 308.1 million in 2018 to USD 832.7 million by 2023, at a CAGR of 22.0% between 2018 and 2023. The demand for biocompatible 3D printing materials, particularly in the implants & prosthesis application, has increased gradually. The tissue engineering application is expected to witness the highest growth during the forecast period.

Browse 65 market data Tables and 33 Figures spread through 110 Pages and in-depth TOC on "Biocompatible 3D Printing Materials Market - Global Forecast to 2023"
https://www.marketsandmarkets.com/Market-Reports/biocompatible-3d-printing-material-market-236523134.html

Early buyers will receive 10% customization on this report.

Increase in demand for biocompatible 3D printing materials in the implants & prosthesis application to drive the market

Implants & prosthesis is the most important and major application of biocompatible 3D printing materials. Biocompatible materials such as polyamide, PEEK, titanium, and cobalt-chrome alloys are widely used in the implants & prosthesis application. These materials when used in 3D printing produce a fine mesh or lattice structure on the surface of surgical implants which can promote better Osseo integration and reduce rejection rates. 3D printing with biocompatible materials provides superior surface geometry and increases the survival rate of medical products over traditional products. The ability to match with the users’ anatomy and high level of customization has made implants & prosthesis the most important application of biocompatible 3D printing materials. The biocompatible 3D printing materials market size is projected to reach USD 832.7 million by 2023, at a CAGR of 22.0% between 2018 and 2023.

The biocompatible 3D printing materials market in APAC is projected to register the highest CAGR during the forecast period. This growth is mainly attributed to the rising geriatric population, increasing focus of major players on emerging Asian countries such as China and India, and willingness of people to spend more on advanced medical treatments.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236523134

On the basis of type, the biocompatible 3D printing materials market is classified into polymer, metal, and others including bioink and ceramic. The bioink segment is projected to register the highest CAGR in the overall biocompatible 3D printing materials market between 2018 and 2023. This high growth can be attributed to the growing demand for bioink in the tissue engineering application.

The powder form segment accounted for the major share in the biocompatible 3D printing materials market and is projected to register the highest CAGR between 2018 and 2023. Powder is also the leading form in the global 3D printing materials market, as it is compatible with several 3D printers. Hence, it is used in medical applications such as implants & prosthesis, tissue engineering, and surgical instruments.
The increasing government investments and adoption of 3D printing technologies in bioprinting organs offer major growth opportunities for the players of the biocompatible 3D printing materials market.

Request Sample@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=236523134

Key players in the benzoic acid market include Emerald Performance Materials (US), Wuhan Youji Industries Co. (China), Tianjin Dongda Chemical Group (China), and Liao Ning Huayi Chemical Industry & Commerce Co. (China), among others.

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com

This release was published on openPR.